Sort
51,593 grants matching “hepatitis”
A Novel Therapeutic for Liver Fibrosis
$1,038,130Prakash Narayan · Angion Biomedica Corporation · R44 · FY2013 · AA
HIV Disease Outcomes in Drug Users in Clinical Practice
$1,038,079Richard Douglas Moore · Johns Hopkins University · R01 · FY2006 · DA
Johns Hopkins AIDS Clinical Trials Unit
$1,038,077Charles W. Flexner · Johns Hopkins University · UM1 · FY2013 · AI
National Neurological AIDS Bank (NNAB)
$1,037,807University Of California Los Angeles · R24 · FY2003 · NS
Functional Genomics Laboratory (FGL)
$1,037,104Ken Cheng · National Center For Advancing Translational Sciences · ZIC · FY2025 · TR
Biliary Atresia Consortium: Data Coordinating Center
$1,036,823University Of Michigan At Ann Arbor · U01 · FY2004 · DK
Incidence of HIV Infection in a Cohort of IV Drug Users
$1,036,759Shruti H Mehta · Johns Hopkins University · R01 · FY2011 · DA
International Studies Of Acquired Immune Deficiency Syndrome (AIDS)
$1,036,099Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Virus-host interactions in hepatocarcinogenesis
$1,035,536J.-H. James Ou · University Of Southern California · P01 · FY2008 · CA
Center for Gastrointestinal Biology and Disease
$1,035,494Robert S Sandler · Univ Of North Carolina Chapel Hill · P30 · FY2018 · DK
Johns Hopkins AIDS Clinical Trials Unit
$1,034,929Charles W. Flexner · Johns Hopkins University · U01 · FY2007 · AI
Immunologic Mechanisms of Alcoholic Liver Disease
$1,033,768Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
$1,033,724Philip Todd Korthuis · Oregon Health & Science University · U01 · FY2021 · TR
Exome Sequencing to Identify CVD Risk Variants in Hispanics & African Americans
$1,032,569Donald W. Bowden · Wake Forest University Health Sciences · R01 · FY2015 · HG
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,032,476Johns Hopkins University · U01 · FY2004 · AI
Adaptable tissue-specific endothelial cells for organ regeneration
$1,032,314Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2020 · HL
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
$1,032,262Natacha Le Moan · Omniox, Inc. · R44 · FY2018 · HD
CLINICAL TRIALS
$1,032,151Massachusetts General Hospital · P01 · FY2000 · CA
Supported employment to create a community culture of SARS-CoV-2 rapid testing among people who inject drugs: PeerConnect2Test
$1,032,060Camille C Cioffi · University Of Oregon · U01 · FY2023 · DA
CIP Genomics Core
$1,032,059Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
STTR Phase II: Monolithic Multiwavelength Blue-to-IR LED for Biomedical Diagnostics
$1,031,972Steven F Leboeuf · Valencell Inc. · · FY2009 · TIP
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$1,031,958Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Xenobiotic receptors
$1,031,958Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$1,031,422Wendy S Post · Johns Hopkins University · R01 · FY2008 · HL
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
$1,031,384Norah A. Terrault · University Of California, San Francisco · U01 · FY2016 · DK